Literature DB >> 28289949

Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.

Bonnie Nga Kwan Choy1, Alex Lap Ki Ng2, Jimmy Shiu Ming Lai2.   

Abstract

PURPOSE: To review the clinical course of adult patients with acute optic neuritis over 10 years in Hong Kong, and the results were compared with other studies among Asian and Caucasian patients.
METHODS: This study retrospectively analysed the clinical features of 38 adult patients (51 eyes) presented with optic neuritis in a Hong Kong hospital over 10 years (2001-2010).
RESULTS: Optic neuritis had a female predominance (68%). The mean age of presentation was 40 years old. Disc swelling (39%) was more common compared to the optic neuritis treatment trial (ONTT). The recovery time ranged from no recovery to 5 years, with a mean of 6.0 months. However, vision continued to deteriorate despite initial improvement in 45% of patients. Only 11.8% of the eyes attained final visual acuity (VA) of 1.0 or better, while 31.4% had VA 0.1 or worse. Multiple sclerosis or neuromyelitis optica only occurred in 10.4% of patients. Three of our patients who did not receive any treatment showed faster recovery than the average.
CONCLUSIONS: Optic neuritis in Hong Kong is mostly a clinically isolated syndrome. Our patients presented at a later age and showed a worse visual outcome. Corticosteroid according to ONTT protocol remained our mainstay of treatment although it did not benefit our patients as much as ONTT study. More work on the long-term prognosis and treatment strategies is worthwhile among Chinese optic neuritis patients.

Entities:  

Keywords:  Demyelinating disease; Hong Kong; Neuroophthalmology; Optic neuritis

Mesh:

Substances:

Year:  2017        PMID: 28289949     DOI: 10.1007/s10792-017-0491-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  19 in total

1.  Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.

Authors:  Andy C O Cheng; Noel C Y Chan; Carmen K M Chan
Journal:  Hong Kong Med J       Date:  2012-04       Impact factor: 2.227

2.  Natural history of the visual impairment of relapsing neuromyelitis optica.

Authors:  Harold Merle; Stéphane Olindo; Mickaël Bonnan; Angélique Donnio; Raymond Richer; Didier Smadja; Philippe Cabre
Journal:  Ophthalmology       Date:  2006-11-30       Impact factor: 12.079

3.  A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.

Authors:  Theodore Krupin; Jeffrey M Liebmann; David S Greenfield; Robert Ritch; Stuart Gardiner
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

4.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

Authors: 
Journal:  Arch Neurol       Date:  2008-06

5.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

6.  Optic neuritis in Hong Kong: a 1-year follow-up study.

Authors:  Patrick P K Lau; Gordon S K Yau; Jacky W Y Lee; Winnie W Y Wong; Victor T Y Tam; Eric Y T Chan; Doris M W Tse; Can Y F Yuen
Journal:  Int Ophthalmol       Date:  2014-04-12       Impact factor: 2.031

7.  Optic neuritis in Singapore.

Authors:  S A Lim; K Y Goh; S Tow; E Fu; T Y Wong; A Seah; C Tan; J F Cullen
Journal:  Singapore Med J       Date:  2008-09       Impact factor: 1.858

8.  Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.

Authors:  L Piccolo; M Woodhall; G Tackley; M Juryńczyk; Y Kong; J Domingos; R Gore; A Vincent; P Waters; M I Leite; J Palace
Journal:  J Neurol       Date:  2015-12-14       Impact factor: 4.849

9.  Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.

Authors: 
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

Review 10.  Management of acute optic neuritis.

Authors:  S J Hickman; C M Dalton; D H Miller; G T Plant
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  2 in total

1.  Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.

Authors:  Guixian Zhao; Qian Chen; Yongheng Huang; Zhenxin Li; Xinghuai Sun; Ping Lu; S Yan; Min Wang; Guohong Tian
Journal:  J Neurol       Date:  2017-11-03       Impact factor: 4.849

2.  Clinical characteristics of optic neuritis phenotypes in a 3-year follow-up Chinese cohort.

Authors:  Chaoyi Feng; Qian Chen; Guixian Zhao; Zhenxin Li; Weimin Chen; Yan Sha; Xinghuai Sun; Min Wang; Guohong Tian
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.